Combating Iron Overload: A Case for Deferoxamine-Based Nanochelators
- 20 May 2020
- journal article
- review article
- Published by Taylor & Francis in Nanomedicine
- Vol. 15 (13) , 1341-1356
Abstract
While iron is a nutrient metal, iron overload can result in multiple organ failures. Iron chelators, such as deferoxamine, are commonly used to ameliorate iron overload conditions. However, their u...Keywords
This publication has 79 references indexed in Scilit:
- Effects of Microparticle Size and Fc Density on Macrophage PhagocytosisPLOS ONE, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and Its Analogues as Highly Potent Dopamine D2/D3 Agonists and as Iron Chelator: In Vivo Activity Indicates Potential Application in Symptomatic and Neuroprotective Therapy for Parkinson’s DiseaseJournal of Medicinal Chemistry, 2010
- Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelatorBlood, 2009
- Body iron metabolism and pathophysiology of iron overloadInternational Journal of Hematology, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Design, Synthesis, and Characterization of Novel Iron Chelators: Structure−Activity Relationships of the 2-Benzoylpyridine Thiosemicarbazone Series and Their 3-Nitrobenzoyl Analogues as Potent Antitumor AgentsJournal of Medicinal Chemistry, 2007
- Iron-chelation properties of phenolic acids bearing catechol and galloyl groupsFood Chemistry, 2006
- The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and CancerPharmacological Reviews, 2005
- Pharmacokinetics of the iron chelator desferrioxamine as affected by liposome encapsulation: Potential in treatment of chronic hemosiderosisLife Sciences, 1978